Personalized medicine (English Wikipedia)

Ray A (20 May 2018). "Artificial Intelligence and Blockchain for Precision Medicine". Compassionate AI. 2 (5). Inner Light Publishers: 60–62. Retrieved 21 May 2018.

analyzegenomes.com (Global: low place; English: low place)

we.analyzegenomes.com

Schapranow MP (27 June 2013). "Analyze Genomes: Motivation". Hasso Plattner Institute. Retrieved 20 July 2014.

apnews.com (Global: 129^th place; English: 89^th place)

"Obama proposes 'precision medicine 'to end one-size-fits-all". AP News. 30 January 2015. Retrieved 20 April 2024.

archives.gov (Global: 446^th place; English: 308^th place)

obamawhitehouse.archives.gov

"The White House Precision Medicine Initiative". whitehouse.gov – via National Archives.

bmj.com (Global: 1,226^th place; English: 1,421^st place)

blogs.bmj.com

Smith R (15 October 2012). "Stratified, personalised, or precision medicine". British Medical Journal. Retrieved 6 January 2016.

breastcancer.org (Global: low place; English: low place)

"Oncotype DX: Genomic Test to Inform Breast Cancer Treatment". 13 June 2019.

cancer.gov (Global: 1,684^th place; English: 1,350^th place)

"Fact Sheet: BRCA1 and BRCA2: Cancer and Genetic Testing". National Cancer Institute (NCI). Retrieved 28 April 2014.

claudiacopeland.com (Global: low place; English: low place)

Precision Medicine: Harnessing the Extraordinary Growth in Medical Data for Personalized Diagnosis and Treatment http://claudiacopeland.com/uploads/3/6/1/4/3614974/hjno_novdec_2016_precision_medicine.pdf Archived 2022-11-13 at the Wayback Machine

dako.com (Global: low place; English: low place)

Carney W (2006). "HER2/neu Status is an Important Biomarker in Guiding Personalized HER2/neu Therapy" (PDF). Connection. 9: 25–27. Archived from the original (PDF) on 4 March 2016. Retrieved 3 January 2014.

datasociety.net (Global: low place; English: low place)

Ferryman K, Pitcan M (26 February 2018). "Fairness in Precision Medicine". Data & Society. Retrieved 27 October 2021.

doi.org (Global: 2^nd place; English: 2^nd place)

Lesko LJ (June 2007). "Personalized medicine: elusive dream or imminent reality?". Clinical Pharmacology and Therapeutics. 81 (6): 807–16. doi:10.1038/sj.clpt.6100204. PMID 17505496. S2CID 17860973.
Priyadharshini VS, Teran LM (2016). "Personalized Medicine in Respiratory Disease". Chapter Five - Personalized Medicine in Respiratory Disease: Role of Proteomics. Advances in Protein Chemistry and Structural Biology. Vol. 102. pp. 115–146. doi:10.1016/bs.apcsb.2015.11.008. ISBN 978-0-12-804795-8. PMID 26827604.
Xie J, Lee S, Chen X (August 2010). Donev R (ed.). "Nanoparticle-based theranostic agents". Advanced Drug Delivery Reviews. Personalized Medicine. 62 (11). Academic Press: 1064–79. doi:10.1016/j.addr.2010.07.009. PMC 2988080. PMID 20691229.
Lu YF, Goldstein DB, Angrist M, et al. (July 2014). "Personalized medicine and human genetic diversity". Cold Spring Harbor Perspectives in Medicine (Essay). 4 (9) a008581. doi:10.1101/cshperspect.a008581. PMC 4143101. PMID 25059740.
Jones DT, Banito A, Grünewald TG, et al. (August 2019). "Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours". Nature Reviews Cancer (Review). 19 (8): 420–438. doi:10.1038/s41568-019-0169-x. PMID 31300807. S2CID 196350118.
Battle A, Mostafavi S, Zhu X, et al. (January 2014). "Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals". Genome Research. 24 (1): 14–24. doi:10.1101/gr.155192.113. PMC 3875855. PMID 24092820.
Cenik C, Cenik ES, Byeon GW, et al. (November 2015). "Integrative analysis of RNA, translation, and protein levels reveals distinct regulatory variation across humans". Genome Research. 25 (11): 1610–21. doi:10.1101/gr.193342.115. PMC 4617958. PMID 26297486.
Wu L, Candille SI, Choi Y, et al. (July 2013). "Variation and genetic control of protein abundance in humans". Nature. 499 (7456): 79–82. Bibcode:2013Natur.499...79W. doi:10.1038/nature12223. PMC 3789121. PMID 23676674.
Snyderman R (August 2012). "Personalized health care: from theory to practice". Biotechnology Journal. 7 (8): 973–9. doi:10.1002/biot.201100297. PMID 22180345. S2CID 31447416.
Altmann A, Beerenwinkel N, Sing T, et al. (2007). "Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance". Antiviral Therapy. 12 (2): 169–78. doi:10.1177/135965350701200202. PMID 17503659. S2CID 26286925. INIST 18647009.
Blau CA, Liakopoulou E (24 October 2012). "Can we deconstruct cancer, one patient at a time?". Opinion. Trends in Genetics. 29 (1). CellPress: 6–10. doi:10.1016/j.tig.2012.09.004. PMC 4221262. PMID 23102584.
Tavassoly I, Hu Y, Zhao S, et al. (August 2019). "Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses". Molecular Oncology. 13 (8): 1725–1743. doi:10.1002/1878-0261.12521. PMC 6670022. PMID 31116490.
Garraway LA, Verweij J, Ballman KV (May 2013). "Precision oncology: an overview". Journal of Clinical Oncology. 31 (15): 1803–5. doi:10.1200/jco.2013.49.4799. hdl:1765/54298. PMID 23589545. S2CID 42163820.
Shrager J, Tenenbaum JM (February 2014). "Rapid learning for precision oncology". Nature Reviews. Clinical Oncology. 11 (2): 109–18. doi:10.1038/nrclinonc.2013.244. PMID 24445514. S2CID 11225698.
Fernandes BS, Williams LM, Steiner J, et al. (April 2017). "The new field of 'precision psychiatry'". BMC Medicine. 15 (1): 80. doi:10.1186/s12916-017-0849-x. PMC 5390384. PMID 28403846.
Fernandes BS, Berk M (June 2017). "Staging in bipolar disorder: one step closer to precision psychiatry". Revista Brasileira de Psiquiatria. 39 (2): 88–89. doi:10.1590/1516-4446-2017-3902. PMC 7111440. PMID 28591270.
Ogino S, Lochhead P, Chan AT, et al. (April 2013). "Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease". Modern Pathology. 26 (4): 465–84. doi:10.1038/modpathol.2012.214. PMC 3637979. PMID 23307060.
Ogino S, Fuchs CS, Giovannucci E (July 2012). "How many molecular subtypes? Implications of the unique tumor principle in personalized medicine". Expert Review of Molecular Diagnostics. 12 (6): 621–628. doi:10.1586/erm.12.46. PMC 3492839. PMID 22845482.
Ogino S, Lochhead P, Giovannucci E, et al. (June 2014). "Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology". Oncogene. 33 (23): 2949–55. doi:10.1038/onc.2013.244. PMC 3818472. PMID 23792451.
Haines JL, Hauser MA, Schmidt S, et al. (April 2005). "Complement factor H variant increases the risk of age-related macular degeneration". Science. 308 (5720): 419–21. Bibcode:2005Sci...308..419H. doi:10.1126/science.1110359. PMID 15761120. S2CID 32716116.
Ashley EA, Butte AJ, Wheeler MT, et al. (May 2010). "Clinical assessment incorporating a personal genome". Lancet. 375 (9725): 1525–35. doi:10.1016/s0140-6736(10)60452-7. PMC 2937184. PMID 20435227.
Huser V, Sincan M, Cimino JJ (2014). "Developing genomic knowledge bases and databases to support clinical management: current perspectives". Pharmacogenomics and Personalized Medicine. 7: 275–83. doi:10.2147/PGPM.S49904. PMC 4175027. PMID 25276091.
Ashley EA (June 2015). "The precision medicine initiative: a new national effort". JAMA. 313 (21): 2119–20. doi:10.1001/jama.2015.3595. PMID 25928209.
Ashley EA (August 2016). "Towards precision medicine". Nature Reviews. Genetics. 17 (9): 507–22. doi:10.1038/nrg.2016.86. PMID 27528417. S2CID 2609065.
Splinter K, Adams DR, Bacino CA, et al. (29 November 2018). "Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease". New England Journal of Medicine. 379 (22): 2131–2139. doi:10.1056/NEJMoa1714458. PMC 6481166. PMID 30304647.
Serpico D, Maziarz M (14 December 2023). "Averaged versus individualized: pragmatic N-of-1 design as a method to investigate individual treatment response". European Journal for Philosophy of Science. 13 (4): 59. doi:10.1007/s13194-023-00559-0. hdl:2434/1045468. ISSN 1879-4920.
Nikles, J., & Mitchell, G. (2015). Nikles J, Mitchell G (eds.). "The Essential Guide to N-of-1 Trials in Health" (PDF). SpringerLink. doi:10.1007/978-94-017-7200-6. ISBN 978-94-017-7199-3. S2CID 33597874.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Belcher A, Mangelsdorf M, McDonald F, et al. (June 2019). "What does Australia's investment in genomics mean for public health?". Australian and New Zealand Journal of Public Health. 43 (3): 204–206. doi:10.1111/1753-6405.12887. PMID 30830712.
Mesko B (2017). "Expert Review of Precision Medicine and Drug Development". Journal Expert Review of Precision Medicine and Drug Development. 2 (5): 239–241. doi:10.1080/23808993.2017.1380516.
Krittanawong C, Zhang H, Wang Z, et al. (May 2017). "Artificial Intelligence in Precision Cardiovascular Medicine". Journal of the American College of Cardiology. 69 (21): 2657–2664. doi:10.1016/j.jacc.2017.03.571. PMID 28545640.
Beacher FD, Mujica-Parodi LR, Gupta S, et al. (5 May 2021). "Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer". Algorithms. 14 (5): 147. doi:10.3390/a14050147.
Bhargava HK, Leo P, Elliott R, et al. (15 April 2020). "Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients". Clinical Cancer Research. 26 (8): 1915–1923. doi:10.1158/1078-0432.CCR-19-2659. ISSN 1557-3265. PMC 7165025. PMID 32139401.
Breckenridge A, Orme M, Wesseling H, et al. (April 1974). "Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man". Clinical Pharmacology and Therapeutics. 15 (4): 424–30. doi:10.1002/cpt1974154424. PMID 4821443. S2CID 11777099.
Rieder MJ, Reiner AP, Gage BF, et al. (June 2005). "Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose". The New England Journal of Medicine. 352 (22): 2285–93. doi:10.1056/NEJMoa044503. PMID 15930419.
Church D, Kerr R, Domingo E, et al. (June 2014). "'Toxgnostics': an unmet need in cancer medicine". Nature Reviews. Cancer. 14 (6): 440–5. doi:10.1038/nrc3729. PMID 24827503. S2CID 21601547.
Kelkar SS, Reineke TM (October 2011). "Theranostics: combining imaging and therapy". Bioconjugate Chemistry. 22 (10): 1879–903. doi:10.1021/bc200151q. PMID 21830812.
Perkovic MN, Erjavec GN, Strac DS, et al. (March 2017). "Theranostic Biomarkers for Schizophrenia". International Journal of Molecular Sciences. 18 (4): 733. doi:10.3390/ijms18040733. PMC 5412319. PMID 28358316.
Kamps R, Brandão RD, Bosch BJ, et al. (January 2017). "Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification". International Journal of Molecular Sciences. 18 (2): 308. doi:10.3390/ijms18020308. PMC 5343844. PMID 28146134.
Yahata N, Kasai K, Kawato M (April 2017). "Computational neuroscience approach to biomarkers and treatments for mental disorders". Psychiatry and Clinical Neurosciences. 71 (4): 215–237. doi:10.1111/pcn.12502. PMID 28032396.
Hamburg MA, Collins FS (July 2010). "The path to personalized medicine". The New England Journal of Medicine. 363 (4): 301–4. doi:10.1056/nejmp1006304. PMID 20551152. S2CID 205106671.
Mancinelli L, Cronin M, Sadée W (2000). "Pharmacogenomics: the promise of personalized medicine". AAPS PharmSci. 2 (1): 29–41. doi:10.1208/ps020104. PMC 2750999. PMID 11741220.
Ellsworth RE, Decewicz DJ, Shriver CD, et al. (May 2010). "Breast cancer in the personal genomics era". Current Genomics. 11 (3): 146–61. doi:10.2174/138920210791110951. PMC 2878980. PMID 21037853.
Wang J, Poon C, Chin D, et al. (1 October 2018). "Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery". Nano Research. 11 (10): 5584–5595. doi:10.1007/s12274-018-2100-2. S2CID 104241223.
Langbein T, Weber WA, Eiber M (September 2019). "Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine". Journal of Nuclear Medicine. 60 (Suppl 2): 13S – 19S. doi:10.2967/jnumed.118.220566. PMID 31481583. S2CID 201830244.
Herrmann K, Schwaiger M, Lewis JS, et al. (March 2020). "Radiotheranostics: a roadmap for future development". The Lancet. Oncology. 21 (3): e146 – e156. doi:10.1016/S1470-2045(19)30821-6. PMC 7367151. PMID 32135118.
Jadvar H, Chen X, Cai W, et al. (February 2018). "Radiotheranostics in Cancer Diagnosis and Management". Radiology. 286 (2): 388–400. doi:10.1148/radiol.2017170346. PMC 5790308. PMID 29356634.
Pandey S, Giovenzana GB, Szikra D, et al. (2021). "Chapter 11. Positron Emission Tomography (PET) Driven Theranostics". Metal Ions in Bio-Imaging Techniques. Springer. pp. 315–346. doi:10.1515/9783110685701-017. S2CID 233659232.
Priyadharshini VS, Teran LM (2020). "Role of respiratory proteomics in precision medicine". In Faintuch J, Faintuch S (eds.). Precision Medicine for Investigators, Practitioners and Providers. Academic Press. pp. 255–261. doi:10.1016/B978-0-12-819178-1.00024-1. ISBN 978-0-12-819178-1. S2CID 213865547.
Fujii K, Nakamura H, Nishimura T (April 2017). "Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma". Expert Review of Proteomics. 14 (4): 373–386. doi:10.1080/14789450.2017.1304215. PMID 28271730. S2CID 3640863.
Lazzari C, Spreafico A, Bachi A, et al. (January 2012). "Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors". Journal of Thoracic Oncology. 7 (1): 40–8. doi:10.1097/JTO.0b013e3182307f17. PMID 21964534. S2CID 205738875.
Telli ML, Hunt SA, Carlson RW, et al. (August 2007). "Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility". Journal of Clinical Oncology. 25 (23): 3525–33. doi:10.1200/JCO.2007.11.0106. PMID 17687157.
Saglio G, Morotti A, Mattioli G, et al. (December 2004). "Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia". Annals of the New York Academy of Sciences. 1028 (1): 423–31. Bibcode:2004NYASA1028..423S. doi:10.1196/annals.1322.050. PMID 15650267. S2CID 19332062.
Pleasance E, Titmuss E, Williamson L, et al. (2020). "Pan-cancer analysis of advanced patient tumours reveals interactions between therapy and genomic landscapes". Nature Cancer. 1 (4): 452–468. doi:10.1038/s43018-020-0050-6. PMID 35121966.
Duffy MJ (July 2001). "Biochemical markers in breast cancer: which ones are clinically useful?". Clinical Biochemistry. 34 (5): 347–52. doi:10.1016/S0009-9120(00)00201-0. PMID 11522269.
Piccart M, Lohrisch C, Di Leo A, et al. (2001). "The predictive value of HER2 in breast cancer". Oncology. 61 Suppl 2 (2): 73–82. doi:10.1159/000055405. PMID 11694791. S2CID 23123767.
Baldus SE, Engelmann K, Hanisch FG (1 January 2004). "MUC1 and the MUCs: a family of human mucins with impact in cancer biology". Critical Reviews in Clinical Laboratory Sciences. 41 (2): 189–231. doi:10.1080/10408360490452040. PMID 15270554. S2CID 46460945.
Cruz JA, Wishart DS (February 2007). "Applications of machine learning in cancer prediction and prognosis". Cancer Informatics. 2: 59–77. CiteSeerX 10.1.1.795.3458. doi:10.1177/117693510600200030. PMC 2675494. PMID 19458758.
Williams MS (August 2019). "Early Lessons from the Implementation of Genomic Medicine Programs". Annual Review of Genomics and Human Genetics. 20 (1): 389–411. doi:10.1146/annurev-genom-083118-014924. PMID 30811224. S2CID 73460688.
Thomas M, Sakoda LC, Hoffmeister M, et al. (September 2020). "Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk". Am J Hum Genet. 107 (3): 432–444. doi:10.1016/j.ajhg.2020.07.006. PMC 7477007. PMID 32758450.
Khera AV, Chaffin M, Aragam KG, et al. (September 2018). "Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations". Nat Genet. 50 (9): 1219–1224. doi:10.1038/s41588-018-0183-z. PMC 6128408. PMID 30104762.
Marnetto D, Pärna K, Läll K, et al. (April 2020). "Ancestry deconvolution and partial polygenic score can improve susceptibility predictions in recently admixed individuals". Nat Commun. 11 (1): 1628. Bibcode:2020NatCo..11.1628M. doi:10.1038/s41467-020-15464-w. PMC 7118071. PMID 32242022.
Wang Y, Guo J, Ni G, et al. (July 2020). "Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations". Nat Commun. 11 (1): 3865. Bibcode:2020NatCo..11.3865W. doi:10.1038/s41467-020-17719-y. PMC 7395791. PMID 32737319.
Martin AR, Kanai M, Kamatani Y, et al. (April 2019). "Clinical use of current polygenic risk scores may exacerbate health disparities". Nat Genet. 51 (4): 584–591. doi:10.1038/s41588-019-0379-x. PMC 6563838. PMID 30926966.
Lewis CM, Vassos E (May 2020). "Polygenic risk scores: from research tools to clinical instruments". Genome Med. 12 (1): 44. doi:10.1186/s13073-020-00742-5. PMC 7236300. PMID 32423490.
Vayena E, Blasimme A, Cohen IG (November 2018). "Machine learning in medicine: Addressing ethical challenges". PLOS Medicine. 15 (11) e1002689. doi:10.1371/journal.pmed.1002689. PMC 6219763. PMID 30399149.
Frueh FW (September 2013). "Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States". Value in Health. 16 (6 Suppl): S27-31. doi:10.1016/j.jval.2013.06.009. PMID 24034309.
Weldon CB, Trosman JR, Gradishar WJ, et al. (July 2012). "Barriers to the use of personalized medicine in breast cancer". Journal of Oncology Practice. 8 (4): e24-31. doi:10.1200/jop.2011.000448. PMC 3396824. PMID 23180995.
Char DS, Shah NH, Magnus D (March 2018). "Implementing Machine Learning in Health Care - Addressing Ethical Challenges". The New England Journal of Medicine. 378 (11): 981–983. doi:10.1056/NEJMp1714229. PMC 5962261. PMID 29539284.
Chernew ME, Landrum MB (March 2018). "Targeted Supplemental Data Collection - Addressing the Quality-Measurement Conundrum". The New England Journal of Medicine. 378 (11): 979–981. doi:10.1056/NEJMp1713834. PMID 29539286.
Gijsberts CM, Groenewegen KA, Hoefer IE, et al. (2 July 2015). "Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events". PLOS ONE. 10 (7) e0132321. Bibcode:2015PLoSO..1032321G. doi:10.1371/journal.pone.0132321. PMC 4489855. PMID 26134404.
Yngvadottir B, Macarthur DG, Jin H, et al. (2009). "The promise and reality of personal genomics". Genome Biology. 10 (9): 237. doi:10.1186/gb-2009-10-9-237. PMC 2768970. PMID 19723346.
Fernald GH, Capriotti E, Daneshjou R, et al. (July 2011). "Bioinformatics challenges for personalized medicine". Bioinformatics. 27 (13): 1741–8. doi:10.1093/bioinformatics/btr295. PMC 3117361. PMID 21596790.

economist.com (Global: 254^th place; English: 236^th place)

events.economist.com

"Building long term sustainable and personalised healthcare systems". Economist. 28 January 2021. Retrieved 17 November 2022.

engineeringchallenges.org (Global: low place; English: low place)

"Grand Challenges - Engineer Better Medicines". www.engineeringchallenges.org. Retrieved 3 August 2020.

fda.gov (Global: 447^th place; English: 338^th place)

"Paving the Way for Personalized Medicine: FDA's Role in a New Era of Medical Product Development" (PDF). U.S. Food and Drug Administration (FDA). October 2013. Archived from the original (PDF) on 23 January 2014. Retrieved 28 April 2014.

futureproofinghealthcare.com (Global: low place; English: low place)

"Personalised and precise healthcare means a better quality of life for patients". future proofing healthcare. Retrieved 17 November 2022.

genome.gov (Global: 9,308^th place; English: 8,899^th place)

"Precision medicine". National Human Genome Research Institute, US National Institutes of Health. 24 April 2024. Retrieved 24 April 2024.
"Personalized medicine". National Human Genome Research Institute, US National Institutes of Health. 24 April 2024. Retrieved 24 April 2024.
"A Catalog of Published Genome-Wide Association Studies". Retrieved 28 June 2015.

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

Garraway LA, Verweij J, Ballman KV (May 2013). "Precision oncology: an overview". Journal of Clinical Oncology. 31 (15): 1803–5. doi:10.1200/jco.2013.49.4799. hdl:1765/54298. PMID 23589545. S2CID 42163820.
Serpico D, Maziarz M (14 December 2023). "Averaged versus individualized: pragmatic N-of-1 design as a method to investigate individual treatment response". European Journal for Philosophy of Science. 13 (4): 59. doi:10.1007/s13194-023-00559-0. hdl:2434/1045468. ISSN 1879-4920.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Wu L, Candille SI, Choi Y, et al. (July 2013). "Variation and genetic control of protein abundance in humans". Nature. 499 (7456): 79–82. Bibcode:2013Natur.499...79W. doi:10.1038/nature12223. PMC 3789121. PMID 23676674.
Haines JL, Hauser MA, Schmidt S, et al. (April 2005). "Complement factor H variant increases the risk of age-related macular degeneration". Science. 308 (5720): 419–21. Bibcode:2005Sci...308..419H. doi:10.1126/science.1110359. PMID 15761120. S2CID 32716116.
Saglio G, Morotti A, Mattioli G, et al. (December 2004). "Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia". Annals of the New York Academy of Sciences. 1028 (1): 423–31. Bibcode:2004NYASA1028..423S. doi:10.1196/annals.1322.050. PMID 15650267. S2CID 19332062.
Marnetto D, Pärna K, Läll K, et al. (April 2020). "Ancestry deconvolution and partial polygenic score can improve susceptibility predictions in recently admixed individuals". Nat Commun. 11 (1): 1628. Bibcode:2020NatCo..11.1628M. doi:10.1038/s41467-020-15464-w. PMC 7118071. PMID 32242022.
Wang Y, Guo J, Ni G, et al. (July 2020). "Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations". Nat Commun. 11 (1): 3865. Bibcode:2020NatCo..11.3865W. doi:10.1038/s41467-020-17719-y. PMC 7395791. PMID 32737319.
Gijsberts CM, Groenewegen KA, Hoefer IE, et al. (2 July 2015). "Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events". PLOS ONE. 10 (7) e0132321. Bibcode:2015PLoSO..1032321G. doi:10.1371/journal.pone.0132321. PMC 4489855. PMID 26134404.

imt.ie (Global: low place; English: low place)

"Ireland performs poorly on international index of personalised healthcare". Irish Medical Times. 9 September 2021. Retrieved 17 November 2022.

inist.fr (Global: 2,854^th place; English: 3,669^th place)

pascal-francis.inist.fr

Altmann A, Beerenwinkel N, Sing T, et al. (2007). "Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance". Antiviral Therapy. 12 (2): 169–78. doi:10.1177/135965350701200202. PMID 17503659. S2CID 26286925. INIST 18647009.

jax.org (Global: low place; English: low place)

genetichealth.jax.org

"Personalized Medicine Benefits - The Jackson Laboratory". jax.org. Archived from the original on 10 May 2015. Retrieved 23 September 2022.

latimes.com (Global: 22^nd place; English: 19^th place)

Clerk J (23 February 2015). "Changing medicine with 3-D bioprinting, where organs can be synthesized by technology". Los Angeles Times.

livescience.com (Global: 1,190^th place; English: 959^th place)

"3D-Printed Medical Devices Spark FDA Evaluation". LiveScience.com. 30 August 2013.

medlineplus.gov (Global: 1,581^st place; English: 1,299^th place)

"What is the difference between precision medicine and personalized medicine? What about pharmacogenomics?". MedlinePlus, National Library of Medicine, US National Institutes of Health. 17 May 2022. Retrieved 24 April 2024.

nature.com (Global: 234^th place; English: 397^th place)

Jones DT, Banito A, Grünewald TG, et al. (August 2019). "Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours". Nature Reviews Cancer (Review). 19 (8): 420–438. doi:10.1038/s41568-019-0169-x. PMID 31300807. S2CID 196350118.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Lesko LJ (June 2007). "Personalized medicine: elusive dream or imminent reality?". Clinical Pharmacology and Therapeutics. 81 (6): 807–16. doi:10.1038/sj.clpt.6100204. PMID 17505496. S2CID 17860973.
Priyadharshini VS, Teran LM (2016). "Personalized Medicine in Respiratory Disease". Chapter Five - Personalized Medicine in Respiratory Disease: Role of Proteomics. Advances in Protein Chemistry and Structural Biology. Vol. 102. pp. 115–146. doi:10.1016/bs.apcsb.2015.11.008. ISBN 978-0-12-804795-8. PMID 26827604.
Xie J, Lee S, Chen X (August 2010). Donev R (ed.). "Nanoparticle-based theranostic agents". Advanced Drug Delivery Reviews. Personalized Medicine. 62 (11). Academic Press: 1064–79. doi:10.1016/j.addr.2010.07.009. PMC 2988080. PMID 20691229.
Lu YF, Goldstein DB, Angrist M, et al. (July 2014). "Personalized medicine and human genetic diversity". Cold Spring Harbor Perspectives in Medicine (Essay). 4 (9) a008581. doi:10.1101/cshperspect.a008581. PMC 4143101. PMID 25059740.
Jones DT, Banito A, Grünewald TG, et al. (August 2019). "Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours". Nature Reviews Cancer (Review). 19 (8): 420–438. doi:10.1038/s41568-019-0169-x. PMID 31300807. S2CID 196350118.
Battle A, Mostafavi S, Zhu X, et al. (January 2014). "Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals". Genome Research. 24 (1): 14–24. doi:10.1101/gr.155192.113. PMC 3875855. PMID 24092820.
Cenik C, Cenik ES, Byeon GW, et al. (November 2015). "Integrative analysis of RNA, translation, and protein levels reveals distinct regulatory variation across humans". Genome Research. 25 (11): 1610–21. doi:10.1101/gr.193342.115. PMC 4617958. PMID 26297486.
Wu L, Candille SI, Choi Y, et al. (July 2013). "Variation and genetic control of protein abundance in humans". Nature. 499 (7456): 79–82. Bibcode:2013Natur.499...79W. doi:10.1038/nature12223. PMC 3789121. PMID 23676674.
Snyderman R (August 2012). "Personalized health care: from theory to practice". Biotechnology Journal. 7 (8): 973–9. doi:10.1002/biot.201100297. PMID 22180345. S2CID 31447416.
Altmann A, Beerenwinkel N, Sing T, et al. (2007). "Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance". Antiviral Therapy. 12 (2): 169–78. doi:10.1177/135965350701200202. PMID 17503659. S2CID 26286925. INIST 18647009.
Blau CA, Liakopoulou E (24 October 2012). "Can we deconstruct cancer, one patient at a time?". Opinion. Trends in Genetics. 29 (1). CellPress: 6–10. doi:10.1016/j.tig.2012.09.004. PMC 4221262. PMID 23102584.
Tavassoly I, Hu Y, Zhao S, et al. (August 2019). "Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses". Molecular Oncology. 13 (8): 1725–1743. doi:10.1002/1878-0261.12521. PMC 6670022. PMID 31116490.
Garraway LA, Verweij J, Ballman KV (May 2013). "Precision oncology: an overview". Journal of Clinical Oncology. 31 (15): 1803–5. doi:10.1200/jco.2013.49.4799. hdl:1765/54298. PMID 23589545. S2CID 42163820.
Shrager J, Tenenbaum JM (February 2014). "Rapid learning for precision oncology". Nature Reviews. Clinical Oncology. 11 (2): 109–18. doi:10.1038/nrclinonc.2013.244. PMID 24445514. S2CID 11225698.
Fernandes BS, Williams LM, Steiner J, et al. (April 2017). "The new field of 'precision psychiatry'". BMC Medicine. 15 (1): 80. doi:10.1186/s12916-017-0849-x. PMC 5390384. PMID 28403846.
Fernandes BS, Berk M (June 2017). "Staging in bipolar disorder: one step closer to precision psychiatry". Revista Brasileira de Psiquiatria. 39 (2): 88–89. doi:10.1590/1516-4446-2017-3902. PMC 7111440. PMID 28591270.
Ogino S, Lochhead P, Chan AT, et al. (April 2013). "Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease". Modern Pathology. 26 (4): 465–84. doi:10.1038/modpathol.2012.214. PMC 3637979. PMID 23307060.
Ogino S, Fuchs CS, Giovannucci E (July 2012). "How many molecular subtypes? Implications of the unique tumor principle in personalized medicine". Expert Review of Molecular Diagnostics. 12 (6): 621–628. doi:10.1586/erm.12.46. PMC 3492839. PMID 22845482.
Ogino S, Lochhead P, Giovannucci E, et al. (June 2014). "Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology". Oncogene. 33 (23): 2949–55. doi:10.1038/onc.2013.244. PMC 3818472. PMID 23792451.
Haines JL, Hauser MA, Schmidt S, et al. (April 2005). "Complement factor H variant increases the risk of age-related macular degeneration". Science. 308 (5720): 419–21. Bibcode:2005Sci...308..419H. doi:10.1126/science.1110359. PMID 15761120. S2CID 32716116.
Ashley EA, Butte AJ, Wheeler MT, et al. (May 2010). "Clinical assessment incorporating a personal genome". Lancet. 375 (9725): 1525–35. doi:10.1016/s0140-6736(10)60452-7. PMC 2937184. PMID 20435227.
Huser V, Sincan M, Cimino JJ (2014). "Developing genomic knowledge bases and databases to support clinical management: current perspectives". Pharmacogenomics and Personalized Medicine. 7: 275–83. doi:10.2147/PGPM.S49904. PMC 4175027. PMID 25276091.
Ashley EA (June 2015). "The precision medicine initiative: a new national effort". JAMA. 313 (21): 2119–20. doi:10.1001/jama.2015.3595. PMID 25928209.
Ashley EA (August 2016). "Towards precision medicine". Nature Reviews. Genetics. 17 (9): 507–22. doi:10.1038/nrg.2016.86. PMID 27528417. S2CID 2609065.
Splinter K, Adams DR, Bacino CA, et al. (29 November 2018). "Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease". New England Journal of Medicine. 379 (22): 2131–2139. doi:10.1056/NEJMoa1714458. PMC 6481166. PMID 30304647.
Belcher A, Mangelsdorf M, McDonald F, et al. (June 2019). "What does Australia's investment in genomics mean for public health?". Australian and New Zealand Journal of Public Health. 43 (3): 204–206. doi:10.1111/1753-6405.12887. PMID 30830712.
Krittanawong C, Zhang H, Wang Z, et al. (May 2017). "Artificial Intelligence in Precision Cardiovascular Medicine". Journal of the American College of Cardiology. 69 (21): 2657–2664. doi:10.1016/j.jacc.2017.03.571. PMID 28545640.
Bhargava HK, Leo P, Elliott R, et al. (15 April 2020). "Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients". Clinical Cancer Research. 26 (8): 1915–1923. doi:10.1158/1078-0432.CCR-19-2659. ISSN 1557-3265. PMC 7165025. PMID 32139401.
Breckenridge A, Orme M, Wesseling H, et al. (April 1974). "Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man". Clinical Pharmacology and Therapeutics. 15 (4): 424–30. doi:10.1002/cpt1974154424. PMID 4821443. S2CID 11777099.
Rieder MJ, Reiner AP, Gage BF, et al. (June 2005). "Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose". The New England Journal of Medicine. 352 (22): 2285–93. doi:10.1056/NEJMoa044503. PMID 15930419.
Church D, Kerr R, Domingo E, et al. (June 2014). "'Toxgnostics': an unmet need in cancer medicine". Nature Reviews. Cancer. 14 (6): 440–5. doi:10.1038/nrc3729. PMID 24827503. S2CID 21601547.
Kelkar SS, Reineke TM (October 2011). "Theranostics: combining imaging and therapy". Bioconjugate Chemistry. 22 (10): 1879–903. doi:10.1021/bc200151q. PMID 21830812.
Perkovic MN, Erjavec GN, Strac DS, et al. (March 2017). "Theranostic Biomarkers for Schizophrenia". International Journal of Molecular Sciences. 18 (4): 733. doi:10.3390/ijms18040733. PMC 5412319. PMID 28358316.
Kamps R, Brandão RD, Bosch BJ, et al. (January 2017). "Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification". International Journal of Molecular Sciences. 18 (2): 308. doi:10.3390/ijms18020308. PMC 5343844. PMID 28146134.
Yahata N, Kasai K, Kawato M (April 2017). "Computational neuroscience approach to biomarkers and treatments for mental disorders". Psychiatry and Clinical Neurosciences. 71 (4): 215–237. doi:10.1111/pcn.12502. PMID 28032396.
Hamburg MA, Collins FS (July 2010). "The path to personalized medicine". The New England Journal of Medicine. 363 (4): 301–4. doi:10.1056/nejmp1006304. PMID 20551152. S2CID 205106671.
Mancinelli L, Cronin M, Sadée W (2000). "Pharmacogenomics: the promise of personalized medicine". AAPS PharmSci. 2 (1): 29–41. doi:10.1208/ps020104. PMC 2750999. PMID 11741220.
Ellsworth RE, Decewicz DJ, Shriver CD, et al. (May 2010). "Breast cancer in the personal genomics era". Current Genomics. 11 (3): 146–61. doi:10.2174/138920210791110951. PMC 2878980. PMID 21037853.
Soni A, Gowthamarajan K, Radhakrishnan A (March 2018). "Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management". International Journal of Pharmaceutical Compounding. 22 (2): 108–121. PMID 29877858.
Langbein T, Weber WA, Eiber M (September 2019). "Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine". Journal of Nuclear Medicine. 60 (Suppl 2): 13S – 19S. doi:10.2967/jnumed.118.220566. PMID 31481583. S2CID 201830244.
Herrmann K, Schwaiger M, Lewis JS, et al. (March 2020). "Radiotheranostics: a roadmap for future development". The Lancet. Oncology. 21 (3): e146 – e156. doi:10.1016/S1470-2045(19)30821-6. PMC 7367151. PMID 32135118.
Jadvar H, Chen X, Cai W, et al. (February 2018). "Radiotheranostics in Cancer Diagnosis and Management". Radiology. 286 (2): 388–400. doi:10.1148/radiol.2017170346. PMC 5790308. PMID 29356634.
Fujii K, Nakamura H, Nishimura T (April 2017). "Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma". Expert Review of Proteomics. 14 (4): 373–386. doi:10.1080/14789450.2017.1304215. PMID 28271730. S2CID 3640863.
Lazzari C, Spreafico A, Bachi A, et al. (January 2012). "Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors". Journal of Thoracic Oncology. 7 (1): 40–8. doi:10.1097/JTO.0b013e3182307f17. PMID 21964534. S2CID 205738875.
Telli ML, Hunt SA, Carlson RW, et al. (August 2007). "Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility". Journal of Clinical Oncology. 25 (23): 3525–33. doi:10.1200/JCO.2007.11.0106. PMID 17687157.
Saglio G, Morotti A, Mattioli G, et al. (December 2004). "Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia". Annals of the New York Academy of Sciences. 1028 (1): 423–31. Bibcode:2004NYASA1028..423S. doi:10.1196/annals.1322.050. PMID 15650267. S2CID 19332062.
Pleasance E, Titmuss E, Williamson L, et al. (2020). "Pan-cancer analysis of advanced patient tumours reveals interactions between therapy and genomic landscapes". Nature Cancer. 1 (4): 452–468. doi:10.1038/s43018-020-0050-6. PMID 35121966.
Duffy MJ (July 2001). "Biochemical markers in breast cancer: which ones are clinically useful?". Clinical Biochemistry. 34 (5): 347–52. doi:10.1016/S0009-9120(00)00201-0. PMID 11522269.
Piccart M, Lohrisch C, Di Leo A, et al. (2001). "The predictive value of HER2 in breast cancer". Oncology. 61 Suppl 2 (2): 73–82. doi:10.1159/000055405. PMID 11694791. S2CID 23123767.
Baldus SE, Engelmann K, Hanisch FG (1 January 2004). "MUC1 and the MUCs: a family of human mucins with impact in cancer biology". Critical Reviews in Clinical Laboratory Sciences. 41 (2): 189–231. doi:10.1080/10408360490452040. PMID 15270554. S2CID 46460945.
Cruz JA, Wishart DS (February 2007). "Applications of machine learning in cancer prediction and prognosis". Cancer Informatics. 2: 59–77. CiteSeerX 10.1.1.795.3458. doi:10.1177/117693510600200030. PMC 2675494. PMID 19458758.
Williams MS (August 2019). "Early Lessons from the Implementation of Genomic Medicine Programs". Annual Review of Genomics and Human Genetics. 20 (1): 389–411. doi:10.1146/annurev-genom-083118-014924. PMID 30811224. S2CID 73460688.
Thomas M, Sakoda LC, Hoffmeister M, et al. (September 2020). "Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk". Am J Hum Genet. 107 (3): 432–444. doi:10.1016/j.ajhg.2020.07.006. PMC 7477007. PMID 32758450.
Khera AV, Chaffin M, Aragam KG, et al. (September 2018). "Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations". Nat Genet. 50 (9): 1219–1224. doi:10.1038/s41588-018-0183-z. PMC 6128408. PMID 30104762.
Marnetto D, Pärna K, Läll K, et al. (April 2020). "Ancestry deconvolution and partial polygenic score can improve susceptibility predictions in recently admixed individuals". Nat Commun. 11 (1): 1628. Bibcode:2020NatCo..11.1628M. doi:10.1038/s41467-020-15464-w. PMC 7118071. PMID 32242022.
Wang Y, Guo J, Ni G, et al. (July 2020). "Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations". Nat Commun. 11 (1): 3865. Bibcode:2020NatCo..11.3865W. doi:10.1038/s41467-020-17719-y. PMC 7395791. PMID 32737319.
Martin AR, Kanai M, Kamatani Y, et al. (April 2019). "Clinical use of current polygenic risk scores may exacerbate health disparities". Nat Genet. 51 (4): 584–591. doi:10.1038/s41588-019-0379-x. PMC 6563838. PMID 30926966.
Lewis CM, Vassos E (May 2020). "Polygenic risk scores: from research tools to clinical instruments". Genome Med. 12 (1): 44. doi:10.1186/s13073-020-00742-5. PMC 7236300. PMID 32423490.
Vayena E, Blasimme A, Cohen IG (November 2018). "Machine learning in medicine: Addressing ethical challenges". PLOS Medicine. 15 (11) e1002689. doi:10.1371/journal.pmed.1002689. PMC 6219763. PMID 30399149.
Frueh FW (September 2013). "Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States". Value in Health. 16 (6 Suppl): S27-31. doi:10.1016/j.jval.2013.06.009. PMID 24034309.
Weldon CB, Trosman JR, Gradishar WJ, et al. (July 2012). "Barriers to the use of personalized medicine in breast cancer". Journal of Oncology Practice. 8 (4): e24-31. doi:10.1200/jop.2011.000448. PMC 3396824. PMID 23180995.
Char DS, Shah NH, Magnus D (March 2018). "Implementing Machine Learning in Health Care - Addressing Ethical Challenges". The New England Journal of Medicine. 378 (11): 981–983. doi:10.1056/NEJMp1714229. PMC 5962261. PMID 29539284.
Chernew ME, Landrum MB (March 2018). "Targeted Supplemental Data Collection - Addressing the Quality-Measurement Conundrum". The New England Journal of Medicine. 378 (11): 979–981. doi:10.1056/NEJMp1713834. PMID 29539286.
Gijsberts CM, Groenewegen KA, Hoefer IE, et al. (2 July 2015). "Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events". PLOS ONE. 10 (7) e0132321. Bibcode:2015PLoSO..1032321G. doi:10.1371/journal.pone.0132321. PMC 4489855. PMID 26134404.
Yngvadottir B, Macarthur DG, Jin H, et al. (2009). "The promise and reality of personal genomics". Genome Biology. 10 (9): 237. doi:10.1186/gb-2009-10-9-237. PMC 2768970. PMID 19723346.
Fernald GH, Capriotti E, Daneshjou R, et al. (July 2011). "Bioinformatics challenges for personalized medicine". Bioinformatics. 27 (13): 1741–8. doi:10.1093/bioinformatics/btr295. PMC 3117361. PMID 21596790.

ncbi.nlm.nih.gov

Xie J, Lee S, Chen X (August 2010). Donev R (ed.). "Nanoparticle-based theranostic agents". Advanced Drug Delivery Reviews. Personalized Medicine. 62 (11). Academic Press: 1064–79. doi:10.1016/j.addr.2010.07.009. PMC 2988080. PMID 20691229.
Lu YF, Goldstein DB, Angrist M, et al. (July 2014). "Personalized medicine and human genetic diversity". Cold Spring Harbor Perspectives in Medicine (Essay). 4 (9) a008581. doi:10.1101/cshperspect.a008581. PMC 4143101. PMID 25059740.
National Research Council (2011), "Glossary", Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease, National Academies Press (US), retrieved 25 April 2024
Battle A, Mostafavi S, Zhu X, et al. (January 2014). "Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals". Genome Research. 24 (1): 14–24. doi:10.1101/gr.155192.113. PMC 3875855. PMID 24092820.
Cenik C, Cenik ES, Byeon GW, et al. (November 2015). "Integrative analysis of RNA, translation, and protein levels reveals distinct regulatory variation across humans". Genome Research. 25 (11): 1610–21. doi:10.1101/gr.193342.115. PMC 4617958. PMID 26297486.
Wu L, Candille SI, Choi Y, et al. (July 2013). "Variation and genetic control of protein abundance in humans". Nature. 499 (7456): 79–82. Bibcode:2013Natur.499...79W. doi:10.1038/nature12223. PMC 3789121. PMID 23676674.
Blau CA, Liakopoulou E (24 October 2012). "Can we deconstruct cancer, one patient at a time?". Opinion. Trends in Genetics. 29 (1). CellPress: 6–10. doi:10.1016/j.tig.2012.09.004. PMC 4221262. PMID 23102584.
Tavassoly I, Hu Y, Zhao S, et al. (August 2019). "Genomic signatures defining responsiveness to allopurinol and combination therapy for lung cancer identified by systems therapeutics analyses". Molecular Oncology. 13 (8): 1725–1743. doi:10.1002/1878-0261.12521. PMC 6670022. PMID 31116490.
Fernandes BS, Williams LM, Steiner J, et al. (April 2017). "The new field of 'precision psychiatry'". BMC Medicine. 15 (1): 80. doi:10.1186/s12916-017-0849-x. PMC 5390384. PMID 28403846.
Fernandes BS, Berk M (June 2017). "Staging in bipolar disorder: one step closer to precision psychiatry". Revista Brasileira de Psiquiatria. 39 (2): 88–89. doi:10.1590/1516-4446-2017-3902. PMC 7111440. PMID 28591270.
Ogino S, Lochhead P, Chan AT, et al. (April 2013). "Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease". Modern Pathology. 26 (4): 465–84. doi:10.1038/modpathol.2012.214. PMC 3637979. PMID 23307060.
Ogino S, Fuchs CS, Giovannucci E (July 2012). "How many molecular subtypes? Implications of the unique tumor principle in personalized medicine". Expert Review of Molecular Diagnostics. 12 (6): 621–628. doi:10.1586/erm.12.46. PMC 3492839. PMID 22845482.
Ogino S, Lochhead P, Giovannucci E, et al. (June 2014). "Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology". Oncogene. 33 (23): 2949–55. doi:10.1038/onc.2013.244. PMC 3818472. PMID 23792451.
Ashley EA, Butte AJ, Wheeler MT, et al. (May 2010). "Clinical assessment incorporating a personal genome". Lancet. 375 (9725): 1525–35. doi:10.1016/s0140-6736(10)60452-7. PMC 2937184. PMID 20435227.
Huser V, Sincan M, Cimino JJ (2014). "Developing genomic knowledge bases and databases to support clinical management: current perspectives". Pharmacogenomics and Personalized Medicine. 7: 275–83. doi:10.2147/PGPM.S49904. PMC 4175027. PMID 25276091.
Splinter K, Adams DR, Bacino CA, et al. (29 November 2018). "Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease". New England Journal of Medicine. 379 (22): 2131–2139. doi:10.1056/NEJMoa1714458. PMC 6481166. PMID 30304647.
Bhargava HK, Leo P, Elliott R, et al. (15 April 2020). "Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients". Clinical Cancer Research. 26 (8): 1915–1923. doi:10.1158/1078-0432.CCR-19-2659. ISSN 1557-3265. PMC 7165025. PMID 32139401.
Perkovic MN, Erjavec GN, Strac DS, et al. (March 2017). "Theranostic Biomarkers for Schizophrenia". International Journal of Molecular Sciences. 18 (4): 733. doi:10.3390/ijms18040733. PMC 5412319. PMID 28358316.
Kamps R, Brandão RD, Bosch BJ, et al. (January 2017). "Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification". International Journal of Molecular Sciences. 18 (2): 308. doi:10.3390/ijms18020308. PMC 5343844. PMID 28146134.
Mancinelli L, Cronin M, Sadée W (2000). "Pharmacogenomics: the promise of personalized medicine". AAPS PharmSci. 2 (1): 29–41. doi:10.1208/ps020104. PMC 2750999. PMID 11741220.
Ellsworth RE, Decewicz DJ, Shriver CD, et al. (May 2010). "Breast cancer in the personal genomics era". Current Genomics. 11 (3): 146–61. doi:10.2174/138920210791110951. PMC 2878980. PMID 21037853.
Herrmann K, Schwaiger M, Lewis JS, et al. (March 2020). "Radiotheranostics: a roadmap for future development". The Lancet. Oncology. 21 (3): e146 – e156. doi:10.1016/S1470-2045(19)30821-6. PMC 7367151. PMID 32135118.
Jadvar H, Chen X, Cai W, et al. (February 2018). "Radiotheranostics in Cancer Diagnosis and Management". Radiology. 286 (2): 388–400. doi:10.1148/radiol.2017170346. PMC 5790308. PMID 29356634.
Cruz JA, Wishart DS (February 2007). "Applications of machine learning in cancer prediction and prognosis". Cancer Informatics. 2: 59–77. CiteSeerX 10.1.1.795.3458. doi:10.1177/117693510600200030. PMC 2675494. PMID 19458758.
Thomas M, Sakoda LC, Hoffmeister M, et al. (September 2020). "Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk". Am J Hum Genet. 107 (3): 432–444. doi:10.1016/j.ajhg.2020.07.006. PMC 7477007. PMID 32758450.
Khera AV, Chaffin M, Aragam KG, et al. (September 2018). "Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations". Nat Genet. 50 (9): 1219–1224. doi:10.1038/s41588-018-0183-z. PMC 6128408. PMID 30104762.
Marnetto D, Pärna K, Läll K, et al. (April 2020). "Ancestry deconvolution and partial polygenic score can improve susceptibility predictions in recently admixed individuals". Nat Commun. 11 (1): 1628. Bibcode:2020NatCo..11.1628M. doi:10.1038/s41467-020-15464-w. PMC 7118071. PMID 32242022.
Wang Y, Guo J, Ni G, et al. (July 2020). "Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations". Nat Commun. 11 (1): 3865. Bibcode:2020NatCo..11.3865W. doi:10.1038/s41467-020-17719-y. PMC 7395791. PMID 32737319.
Martin AR, Kanai M, Kamatani Y, et al. (April 2019). "Clinical use of current polygenic risk scores may exacerbate health disparities". Nat Genet. 51 (4): 584–591. doi:10.1038/s41588-019-0379-x. PMC 6563838. PMID 30926966.
Lewis CM, Vassos E (May 2020). "Polygenic risk scores: from research tools to clinical instruments". Genome Med. 12 (1): 44. doi:10.1186/s13073-020-00742-5. PMC 7236300. PMID 32423490.
Vayena E, Blasimme A, Cohen IG (November 2018). "Machine learning in medicine: Addressing ethical challenges". PLOS Medicine. 15 (11) e1002689. doi:10.1371/journal.pmed.1002689. PMC 6219763. PMID 30399149.
Weldon CB, Trosman JR, Gradishar WJ, et al. (July 2012). "Barriers to the use of personalized medicine in breast cancer". Journal of Oncology Practice. 8 (4): e24-31. doi:10.1200/jop.2011.000448. PMC 3396824. PMID 23180995.
Char DS, Shah NH, Magnus D (March 2018). "Implementing Machine Learning in Health Care - Addressing Ethical Challenges". The New England Journal of Medicine. 378 (11): 981–983. doi:10.1056/NEJMp1714229. PMC 5962261. PMID 29539284.
Gijsberts CM, Groenewegen KA, Hoefer IE, et al. (2 July 2015). "Race/Ethnic Differences in the Associations of the Framingham Risk Factors with Carotid IMT and Cardiovascular Events". PLOS ONE. 10 (7) e0132321. Bibcode:2015PLoSO..1032321G. doi:10.1371/journal.pone.0132321. PMC 4489855. PMID 26134404.
Yngvadottir B, Macarthur DG, Jin H, et al. (2009). "The promise and reality of personal genomics". Genome Biology. 10 (9): 237. doi:10.1186/gb-2009-10-9-237. PMC 2768970. PMID 19723346.
Fernald GH, Capriotti E, Daneshjou R, et al. (July 2011). "Bioinformatics challenges for personalized medicine". Bioinformatics. 27 (13): 1741–8. doi:10.1093/bioinformatics/btr295. PMC 3117361. PMID 21596790.

nih.gov

"Near-term Goals". nih.gov. Archived from the original on 2 February 2015.
"Longer-term Goals". nih.gov. Archived from the original on 3 February 2015.

report.nih.gov

"Research Portfolio Online Reporting Tools: Human Genome Project". National Institutes of Health (NIH). Archived from the original on 25 September 2019. Retrieved 28 April 2014.

ghr.nlm.nih.gov

"Genetics Home Reference: What is pharmacogenomics?". National Institutes of Health (NIH). Archived from the original on 29 September 2006. Retrieved 28 April 2014.

personalizedmedicinecoalition.org (Global: low place; English: low place)

"The Case for Personalized Medicine" (PDF). Personalized Medicine Coalition. 2014. Retrieved 6 January 2016.
"Personalized Medicine 101". Personalized Medicine Coalition. Archived from the original on 10 May 2019. Retrieved 26 April 2014.
"Personalized Medicine 101: The Science". Personalized Medicine Coalition. Archived from the original on 19 February 2019. Retrieved 26 April 2014.
"Personalized Medicine 101: The Promise". Personalized Medicine Coalition. Archived from the original on 19 December 2017. Retrieved 26 April 2014.
"Personalized Medicine 101: The Challenges". Personalized Medicine Coalition. Archived from the original on 3 May 2014. Retrieved 26 April 2014.

pmlive.com (Global: low place; English: low place)

"Divining your future in healthcare". pmlive.com. 18 October 2013.

psu.edu (Global: 207^th place; English: 136^th place)

citeseerx.ist.psu.edu

Cruz JA, Wishart DS (February 2007). "Applications of machine learning in cancer prediction and prognosis". Cancer Informatics. 2: 59–77. CiteSeerX 10.1.1.795.3458. doi:10.1177/117693510600200030. PMC 2675494. PMID 19458758.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Lesko LJ (June 2007). "Personalized medicine: elusive dream or imminent reality?". Clinical Pharmacology and Therapeutics. 81 (6): 807–16. doi:10.1038/sj.clpt.6100204. PMID 17505496. S2CID 17860973.
Jones DT, Banito A, Grünewald TG, et al. (August 2019). "Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours". Nature Reviews Cancer (Review). 19 (8): 420–438. doi:10.1038/s41568-019-0169-x. PMID 31300807. S2CID 196350118.
Snyderman R (August 2012). "Personalized health care: from theory to practice". Biotechnology Journal. 7 (8): 973–9. doi:10.1002/biot.201100297. PMID 22180345. S2CID 31447416.
Altmann A, Beerenwinkel N, Sing T, et al. (2007). "Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance". Antiviral Therapy. 12 (2): 169–78. doi:10.1177/135965350701200202. PMID 17503659. S2CID 26286925. INIST 18647009.
Garraway LA, Verweij J, Ballman KV (May 2013). "Precision oncology: an overview". Journal of Clinical Oncology. 31 (15): 1803–5. doi:10.1200/jco.2013.49.4799. hdl:1765/54298. PMID 23589545. S2CID 42163820.
Shrager J, Tenenbaum JM (February 2014). "Rapid learning for precision oncology". Nature Reviews. Clinical Oncology. 11 (2): 109–18. doi:10.1038/nrclinonc.2013.244. PMID 24445514. S2CID 11225698.
Haines JL, Hauser MA, Schmidt S, et al. (April 2005). "Complement factor H variant increases the risk of age-related macular degeneration". Science. 308 (5720): 419–21. Bibcode:2005Sci...308..419H. doi:10.1126/science.1110359. PMID 15761120. S2CID 32716116.
Ashley EA (August 2016). "Towards precision medicine". Nature Reviews. Genetics. 17 (9): 507–22. doi:10.1038/nrg.2016.86. PMID 27528417. S2CID 2609065.
Nikles, J., & Mitchell, G. (2015). Nikles J, Mitchell G (eds.). "The Essential Guide to N-of-1 Trials in Health" (PDF). SpringerLink. doi:10.1007/978-94-017-7200-6. ISBN 978-94-017-7199-3. S2CID 33597874.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Breckenridge A, Orme M, Wesseling H, et al. (April 1974). "Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man". Clinical Pharmacology and Therapeutics. 15 (4): 424–30. doi:10.1002/cpt1974154424. PMID 4821443. S2CID 11777099.
Church D, Kerr R, Domingo E, et al. (June 2014). "'Toxgnostics': an unmet need in cancer medicine". Nature Reviews. Cancer. 14 (6): 440–5. doi:10.1038/nrc3729. PMID 24827503. S2CID 21601547.
Hamburg MA, Collins FS (July 2010). "The path to personalized medicine". The New England Journal of Medicine. 363 (4): 301–4. doi:10.1056/nejmp1006304. PMID 20551152. S2CID 205106671.
Wang J, Poon C, Chin D, et al. (1 October 2018). "Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery". Nano Research. 11 (10): 5584–5595. doi:10.1007/s12274-018-2100-2. S2CID 104241223.
Langbein T, Weber WA, Eiber M (September 2019). "Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine". Journal of Nuclear Medicine. 60 (Suppl 2): 13S – 19S. doi:10.2967/jnumed.118.220566. PMID 31481583. S2CID 201830244.
Pandey S, Giovenzana GB, Szikra D, et al. (2021). "Chapter 11. Positron Emission Tomography (PET) Driven Theranostics". Metal Ions in Bio-Imaging Techniques. Springer. pp. 315–346. doi:10.1515/9783110685701-017. S2CID 233659232.
Priyadharshini VS, Teran LM (2020). "Role of respiratory proteomics in precision medicine". In Faintuch J, Faintuch S (eds.). Precision Medicine for Investigators, Practitioners and Providers. Academic Press. pp. 255–261. doi:10.1016/B978-0-12-819178-1.00024-1. ISBN 978-0-12-819178-1. S2CID 213865547.
Fujii K, Nakamura H, Nishimura T (April 2017). "Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma". Expert Review of Proteomics. 14 (4): 373–386. doi:10.1080/14789450.2017.1304215. PMID 28271730. S2CID 3640863.
Lazzari C, Spreafico A, Bachi A, et al. (January 2012). "Changes in plasma mass-spectral profile in course of treatment of non-small cell lung cancer patients with epidermal growth factor receptor tyrosine kinase inhibitors". Journal of Thoracic Oncology. 7 (1): 40–8. doi:10.1097/JTO.0b013e3182307f17. PMID 21964534. S2CID 205738875.
Saglio G, Morotti A, Mattioli G, et al. (December 2004). "Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia". Annals of the New York Academy of Sciences. 1028 (1): 423–31. Bibcode:2004NYASA1028..423S. doi:10.1196/annals.1322.050. PMID 15650267. S2CID 19332062.
Piccart M, Lohrisch C, Di Leo A, et al. (2001). "The predictive value of HER2 in breast cancer". Oncology. 61 Suppl 2 (2): 73–82. doi:10.1159/000055405. PMID 11694791. S2CID 23123767.
Baldus SE, Engelmann K, Hanisch FG (1 January 2004). "MUC1 and the MUCs: a family of human mucins with impact in cancer biology". Critical Reviews in Clinical Laboratory Sciences. 41 (2): 189–231. doi:10.1080/10408360490452040. PMID 15270554. S2CID 46460945.
Williams MS (August 2019). "Early Lessons from the Implementation of Genomic Medicine Programs". Annual Review of Genomics and Human Genetics. 20 (1): 389–411. doi:10.1146/annurev-genom-083118-014924. PMID 30811224. S2CID 73460688.

snmjournals.org (Global: low place; English: low place)

jnm.snmjournals.org

Langbein T, Weber WA, Eiber M (September 2019). "Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine". Journal of Nuclear Medicine. 60 (Suppl 2): 13S – 19S. doi:10.2967/jnumed.118.220566. PMID 31481583. S2CID 201830244.

springer.com (Global: 274^th place; English: 309^th place)

link.springer.com

Nikles, J., & Mitchell, G. (2015). Nikles J, Mitchell G (eds.). "The Essential Guide to N-of-1 Trials in Health" (PDF). SpringerLink. doi:10.1007/978-94-017-7200-6. ISBN 978-94-017-7199-3. S2CID 33597874.{{cite journal}}: CS1 maint: multiple names: authors list (link)

washingtonpost.com (Global: 34^th place; English: 27^th place)

Cunningham PW (16 January 2018). "The Health 202: NIH wants 1 million Americans to contribute to new pool of gene data". The Washington Post. ISSN 0190-8286. Retrieved 20 January 2018.

web.archive.org (Global: 1^st place; English: 1^st place)

Stratified, personalized or P4 medicine: a new direction for placing the patient at the center of healthcare and health education (Technical report). Academy of Medical Sciences. May 2015. Archived from the original on 27 October 2016. Retrieved 6 January 2016.
"Personalized Medicine 101". Personalized Medicine Coalition. Archived from the original on 10 May 2019. Retrieved 26 April 2014.
President's Council of Advisors on Science and Technology (September 2008). "Priorities for Personalized Medicine" (PDF). The White House. p. 19. Archived from the original (PDF) on 10 June 2016. Retrieved 24 April 2024.
"Personalized Medicine 101: The Science". Personalized Medicine Coalition. Archived from the original on 19 February 2019. Retrieved 26 April 2014.
Precision Medicine: Harnessing the Extraordinary Growth in Medical Data for Personalized Diagnosis and Treatment http://claudiacopeland.com/uploads/3/6/1/4/3614974/hjno_novdec_2016_precision_medicine.pdf Archived 2022-11-13 at the Wayback Machine
"Personalized Medicine Benefits - The Jackson Laboratory". jax.org. Archived from the original on 10 May 2015. Retrieved 23 September 2022.
"Near-term Goals". nih.gov. Archived from the original on 2 February 2015.
"Longer-term Goals". nih.gov. Archived from the original on 3 February 2015.
"Personalized Medicine 101: The Promise". Personalized Medicine Coalition. Archived from the original on 19 December 2017. Retrieved 26 April 2014.
"Research Portfolio Online Reporting Tools: Human Genome Project". National Institutes of Health (NIH). Archived from the original on 25 September 2019. Retrieved 28 April 2014.
"Genetics Home Reference: What is pharmacogenomics?". National Institutes of Health (NIH). Archived from the original on 29 September 2006. Retrieved 28 April 2014.
"BIOMARKER TOOLKIT: Companion Diagnostics" (PDF). Amgen. Archived from the original (PDF) on 1 August 2014. Retrieved 2 May 2014.
"Paving the Way for Personalized Medicine: FDA's Role in a New Era of Medical Product Development" (PDF). U.S. Food and Drug Administration (FDA). October 2013. Archived from the original (PDF) on 23 January 2014. Retrieved 28 April 2014.
Carney W (2006). "HER2/neu Status is an Important Biomarker in Guiding Personalized HER2/neu Therapy" (PDF). Connection. 9: 25–27. Archived from the original (PDF) on 4 March 2016. Retrieved 3 January 2014.
"Personalized Medicine 101: The Challenges". Personalized Medicine Coalition. Archived from the original on 3 May 2014. Retrieved 26 April 2014.

weillcornell.org (Global: low place; English: low place)

"The Impact of Precision Medicine on Cancer". weillcornell.org.

whitehouse.gov (Global: 1,241^st place; English: 1,069^th place)

President's Council of Advisors on Science and Technology (September 2008). "Priorities for Personalized Medicine" (PDF). The White House. p. 19. Archived from the original (PDF) on 10 June 2016. Retrieved 24 April 2024.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Serpico D, Maziarz M (14 December 2023). "Averaged versus individualized: pragmatic N-of-1 design as a method to investigate individual treatment response". European Journal for Philosophy of Science. 13 (4): 59. doi:10.1007/s13194-023-00559-0. hdl:2434/1045468. ISSN 1879-4920.
Bhargava HK, Leo P, Elliott R, et al. (15 April 2020). "Computationally Derived Image Signature of Stromal Morphology Is Prognostic of Prostate Cancer Recurrence Following Prostatectomy in African American Patients". Clinical Cancer Research. 26 (8): 1915–1923. doi:10.1158/1078-0432.CCR-19-2659. ISSN 1557-3265. PMC 7165025. PMID 32139401.
Cunningham PW (16 January 2018). "The Health 202: NIH wants 1 million Americans to contribute to new pool of gene data". The Washington Post. ISSN 0190-8286. Retrieved 20 January 2018.

Personalized medicine (English Wikipedia)

acmedsci.ac.uk (Global: low place; English: low place)

aipla.org (Global: low place; English: low place)

amgen.com (Global: low place; English: low place)

amitray.com (Global: low place; English: low place)

analyzegenomes.com (Global: low place; English: low place)

we.analyzegenomes.com

apnews.com (Global: 129th place; English: 89th place)

archives.gov (Global: 446th place; English: 308th place)

obamawhitehouse.archives.gov

bmj.com (Global: 1,226th place; English: 1,421st place)

blogs.bmj.com

breastcancer.org (Global: low place; English: low place)

cancer.gov (Global: 1,684th place; English: 1,350th place)

claudiacopeland.com (Global: low place; English: low place)

dako.com (Global: low place; English: low place)

datasociety.net (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

economist.com (Global: 254th place; English: 236th place)

events.economist.com

engineeringchallenges.org (Global: low place; English: low place)

fda.gov (Global: 447th place; English: 338th place)

futureproofinghealthcare.com (Global: low place; English: low place)

genome.gov (Global: 9,308th place; English: 8,899th place)

handle.net (Global: 102nd place; English: 76th place)

hdl.handle.net

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

imt.ie (Global: low place; English: low place)

inist.fr (Global: 2,854th place; English: 3,669th place)

pascal-francis.inist.fr

jax.org (Global: low place; English: low place)

genetichealth.jax.org

latimes.com (Global: 22nd place; English: 19th place)

livescience.com (Global: 1,190th place; English: 959th place)

medlineplus.gov (Global: 1,581st place; English: 1,299th place)

nature.com (Global: 234th place; English: 397th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nih.gov

report.nih.gov

ghr.nlm.nih.gov

personalizedmedicinecoalition.org (Global: low place; English: low place)

pmlive.com (Global: low place; English: low place)

psu.edu (Global: 207th place; English: 136th place)

citeseerx.ist.psu.edu

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

snmjournals.org (Global: low place; English: low place)

jnm.snmjournals.org

springer.com (Global: 274th place; English: 309th place)

link.springer.com

washingtonpost.com (Global: 34th place; English: 27th place)

web.archive.org (Global: 1st place; English: 1st place)

weillcornell.org (Global: low place; English: low place)

whitehouse.gov (Global: 1,241st place; English: 1,069th place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

apnews.com (Global: 129^th place; English: 89^th place)

archives.gov (Global: 446^th place; English: 308^th place)

bmj.com (Global: 1,226^th place; English: 1,421^st place)

cancer.gov (Global: 1,684^th place; English: 1,350^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

economist.com (Global: 254^th place; English: 236^th place)

fda.gov (Global: 447^th place; English: 338^th place)

genome.gov (Global: 9,308^th place; English: 8,899^th place)

handle.net (Global: 102^nd place; English: 76^th place)

harvard.edu (Global: 18^th place; English: 17^th place)

inist.fr (Global: 2,854^th place; English: 3,669^th place)

latimes.com (Global: 22^nd place; English: 19^th place)

livescience.com (Global: 1,190^th place; English: 959^th place)

medlineplus.gov (Global: 1,581^st place; English: 1,299^th place)

nature.com (Global: 234^th place; English: 397^th place)

nih.gov (Global: 4^th place; English: 4^th place)

psu.edu (Global: 207^th place; English: 136^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

springer.com (Global: 274^th place; English: 309^th place)

washingtonpost.com (Global: 34^th place; English: 27^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

whitehouse.gov (Global: 1,241^st place; English: 1,069^th place)

worldcat.org (Global: 5^th place; English: 5^th place)